Resources

Very difficult in many patients with diabetes and cardiovascular disease, to attain an LDL goal of

Effects of Exenatide (Exendin-4) on Glycemic Control on Patients Taking Sulfonylurea + Metformin Results show a weight loss and a drop in A1c of 1 point over 30 weeks.

Exenatide reduced HbA1c with no weight gain and no increased incidence of hypoglycemia in patients failing to achieve glycemic control with metformin.

Risk of dementia was increased by 74% in obese people), and by 35% in overweight people

Women who take rosiglitazone during pregnancy can expect some of the drug to reach the fetus during the first trimester, new research shows.

Use of glipizide and metformin can increase the incidence of cardiovascular events.

The findings might be clinically relevant in the prediction of patients who will respond best to rosiglitazone treatment.

Scientists from Stanford University in California have identified a method to induce brain-derived human neural progenitor cells to form insulin-producing cells (IPCs).

Sleeping for less than six hours or for more than nine hours each night is associated with an increased risk of diabetes and impaired blood sugar (glucose) tolerance by 2.5-fold.

Depression appears to increase the risk of developing diabetes by 23% in younger adults.New